Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) for CNY 0 on January 19, 2024. As of September 30, 2023, in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. generated total assets of CNY 3.1 million and net assets of CNY 3.1 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.3 CNY | -0.07% |
|
-7.10% | -42.63% |
1st Jan change | Capi. | |
---|---|---|
-42.63% | 166M | |
+59.97% | 840B | |
+37.87% | 621B | |
-6.18% | 354B | |
+15.61% | 319B | |
+8.44% | 297B | |
+13.26% | 237B | |
+14.72% | 221B | |
+0.90% | 220B | |
+9.68% | 169B |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. for CNY 0.